CSL's 2026 Impact Report

Spanning five therapeutic areas: We deliver our portfolio of lifesaving medicines through our three businesses: Legend Countries where CSL provides medicines and vaccines Countries where CSL does not currently provide medicines and vaccines Map reflects countries where CSL products are registered or supplied as of September 2026.or supplied as at September 2026. CSL Behring Leading the way in treating rare and serious diseases CSL Behring discovers, develops and delivers innovative therapies for people living with a range of rare and serious health conditions. CSL Seqirus Securing health for all of us CSL Seqirus is a leader in the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Vifor Changing the game in iron deficiency and nephrology CSL Vifor is a global leader in therapies for iron deficiency and nephrology. CSL IMPACT REPORT 2026 | 11

RkJQdWJsaXNoZXIy MjE2NDg3